|
Q3 2024
|
71 |
445,291 |
NUVL, MRUS, INSM, RNA
|
13F-HR
|
11/14/2024 |
000142050624002416 |
|
Q2 2024
|
70 |
423,865 |
MRUS, NUVL, RNA, URGN
|
13F-HR
|
8/14/2024 |
000142050624001528 |
|
Q1 2024
|
77 |
360,052 |
MRUS, SLDB, MORF, ORIC
|
13F-HR
|
5/14/2024 |
000142050624000871 |
|
Q4 2023
|
67 |
335,961 |
MRUS, MRSN, MORF, NUVL
|
13F-HR
|
2/14/2024 |
000142050624000388 |
|
Q3 2023
|
80 |
329,815 |
XBI calls, IMGN, MORF, MRUS
|
13F-HR
|
11/13/2023 |
000142050623001985 |
|
Q2 2023
|
82 |
323,278 |
IMGN, MRUS, MORF, SDGR
|
13F-HR
|
8/14/2023 |
000142050623001582 |
|
Q1 2023
|
72 |
242,254 |
MRUS, MGNX, VRAY, PSTX
|
13F-HR
|
5/15/2023 |
000142050623001081 |
|
Q4 2022
|
90 |
349,550 |
RXDX puts, MDGL, BLU.TO, PSTX
|
13F-HR
|
2/14/2023 |
000142050623000635 |
|
Q3 2022
|
79 |
295,642 |
BLU.TO, RLMD puts, RXDX puts, VCYT
|
13F-HR
|
10/28/2022 |
000142050622001926 |
|
Q2 2022
|
70 |
324,790 |
QQQ puts, ITCI, XBI calls, BLU.TO
|
13F-HR
|
7/25/2022 |
000142050622001285 |
|
Q1 2022
|
69 |
241,648 |
ATHA, XBI calls, ITCI, SRRA
|
13F-HR
|
5/13/2022 |
000142050622000940 |
|
Q4 2021
|
71 |
246,753 |
XBI calls, IMGN, BIOHAVEN PHARMACTL HLDG CO L, ITCI
|
13F-HR
|
2/14/2022 |
000142050622000341 |
|
Q3 2021
|
82 |
176,882 |
BIOHAVEN PHARMACTL HLDG CO L, VCYT, MRTX, MRUS
|
13F-HR
|
11/15/2021 |
000142050621001696 |
|
Q2 2021
|
96 |
224,217 |
KDNY, XBI calls, DRNA, MRUS
|
13F-HR
|
8/16/2021 |
000142050621001278 |
|
Q1 2021
|
91 |
183,333 |
ACRS, CRIS, VCEL, INSM
|
13F-HR
|
5/17/2021 |
000142050621000796 |
|
Q4 2020
|
84 |
172,124 |
VCEL, BIOGEN INC calls, ITCI, DCTH
|
13F-HR
|
2/16/2021 |
000142050621000331 |